# A Clinical Trial to Study Single- and Multiple- Doses of GSM-779690T in Healthy Participants

> **NCT07155980** · PHASE1 · WITHDRAWN · sponsor: **Acta Pharmaceuticals, Inc**

## Conditions studied

- Healthy Adult Participants

## Interventions

- **DRUG:** GSM-779690T
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07155980
- **Lead sponsor:** Acta Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-11-09
- **Primary completion:** 2026-07-11
- **Final completion:** 2026-07-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The protocol is being withdrawn prior to enrollment due to a redesign of the study approach under the existing IND.
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07155980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07155980, "A Clinical Trial to Study Single- and Multiple- Doses of GSM-779690T in Healthy Participants". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07155980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*